Tempest Therapeutics Net Profit Margin Growth & History (TPST)

Tempest Therapeutics's net profit margin was −28,670.51% for fiscal 2017.

View full Tempest Therapeutics company overview

Tempest Therapeutics annual net profit margin history

Tempest Therapeutics annual net profit margin

Fiscal yearPeriod endedNet profit marginChange (percentage points)
20172017-12-31−28,670.51%−16073.26 pp
20162016-12-31−12,597.24%+13835.61 pp
20152015-12-31−26,432.85%

Tempest Therapeutics net profit margin trends

Between the periods ended 2015-12-31 and 2017-12-31, Tempest Therapeutics's net profit margin decreased from −26,432.85% to −28,670.51%, a change of −2237.66 percentage points. The latest reported quarter, Q3 2018, shows −13,701.82%.

About the metric

What net profit margin means

Net profit margin measures the percentage of revenue remaining as net income after operating costs, interest, taxes, and other expenses. It shows how much bottom-line profit or loss a company generates from each dollar of revenue.

Calculation and source

How net profit margin is calculated

TickerStat calculates net profit margin as SEC-reported net income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Tempest Therapeutics source filings ↗

Community posts

It’s quiet here.

No posts about TPST yet. Start the conversation.

Write the first post